Clinical Trials: US Diversity Action Plans Could Benefit From EQBMED Pilot Program

The Equitable Breakthroughs in Medicine Development initiative, funded with a PhRMA grant, provides sites in historically under-represented communities with support to conduct clinical research. In an interview, EQBMED’s Tesheia Johnson Harris talks about the local sites selected, therapeutic areas for research, and learnings to date.

Communities of color
EQBMED is identifying community-facing clinical trial sites in historically under-represented communities of color. (Shutterstock)
Key Takeaways
  • EQBMED provides community-facing clinical trial sites with support for study capabilities and public engagement.
  • The initiative’s “learning phase” includes 10 local sites and five pharmaceutical company partners.
  • The community and site-level engagement necessary to bring trials to areas historically under-represented in clinical research should help sponsors develop diversity action plans.

The Equitable Breakthroughs in Medicine Development (EQBMED) pilot program’s lessons for bringing clinical trials to underserved areas could help inform sponsors’ trial diversity actions, which are expected to be required...

EQBMED is a multi-stakeholder effort aiming for equity in clinical research by providing community-facing clinical trial sites with robust support across community engagement and clinical trial operations capabilities.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Interviews

More from R&D